Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Xeris Biopharma Holdings, Inc. (XERS) had Debt to Equity Ratio of -28.15 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$163.91M |
|
$-62.26M |
|
$28.64M |
|
$135.27M |
|
$207.92M |
|
$-44.01M |
|
$-19.49M |
|
$-63.50M |
|
$-63.50M |
|
$-62.26M |
|
$-62.26M |
|
$-62.26M |
|
$-62.26M |
|
$-44.01M |
|
$-28.64M |
|
137.68M |
|
137.68M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$156.26M |
|
$5.97M |
|
$166.34M |
|
$322.60M |
|
$95.19M |
|
$190.93M |
|
$234.19M |
|
$329.38M |
|
$-6.78M |
|
$-139.41M |
|
$-6.78M |
|
138.13M |
|
| Cash Flow Statement Financials | |
$-47.02M |
|
$-6.00M |
|
$-1.61M |
|
$126.31M |
|
$71.67M |
|
$-54.64M |
|
$10.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.64 |
|
-- |
|
-- |
|
1.04 |
|
|
Debt to Equity Ratio |
-28.15 |
82.52% |
|
-26.85% |
|
-26.85% |
|
-17.48% |
|
-38.74% |
|
-37.98% |
|
$-49.29M |
|
-- |
|
-- |
|
-- |
|
0.51 |
|
0.74 |
|
4.18 |
|
87.28 |
|
917.94% |
|
44.66% |
|
-19.30% |
|
-33.81% |
|
$-0.05 |
|
$-0.36 |
|
$-0.34 |
|